Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Sangeeta Jethwa"'
Autor:
Markus Joerger, Emiliano Calvo, Heinz Läubli, Juanita Lopez, Elena Garralda, Dagmar Hess, Elena Corral de la Fuente, Christoph Bucher, Guzman Alonso, Sangeeta Jethwa, David König, Vicky Sanchez Perez
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 11 (2023)
Background ANV419 is a stable antibody–cytokine fusion protein consisting of interleukin-2 (IL-2) fused to an anti-IL-2 monoclonal antibody that sterically hinders binding of IL-2 to the α subunit of its receptor but has selective affinity for the
Externí odkaz:
https://doaj.org/article/c922b1eb4e8b44009c63d9e58c5680a1
Publikováno v:
Biologics: Targets & Therapy, Vol 2008, Iss Issue 3, Pp 517-530 (2008)
Bernard Escudier1, Jan Cosaert2, Sangeeta Jethwa21Unité Immunothérapie, Institut Gustave Roussy, Villejuif, France; 2F. Hoffmann-La Roche Ltd, Basel, SwitzerlandAbstract: Bevacizumab (10 mg/kg every 2 weeks), in combination with interferon alpha-2a
Externí odkaz:
https://doaj.org/article/d19bb4fcab0d4f1794b552ac3168d89d
Autor:
Christoph Bucher, Guzman Alonso, Juanita Lopez, Emiliano Calvo, Markus Joerger, Vicky Sanchez Perez, Elena Corral, Daniela Di Blasi, Kirsten Richter, Christoph Huber, Julie Mouton, Silvio Costanzo, Sangeeta Jethwa, Elena Gerralda, Heinz Läubli
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Dylan Trundell, Anne Skalicky, Hannah Staunton, Asha Hareendran, Stephanie Le Scouiller, Louise Barrett, Owen Cooper, Ksenija Gorni, Tim Seabrook, Sangeeta Jethwa, Stefan Cano
Publikováno v:
Journal of the neurological sciences. 432
The amount of assistance required to perform daily activities for individuals with Type 2 and non-ambulant Type 3 spinal muscular atrophy (SMA) is often cited as meaningful for quality of life, and important to routinely assess.The SMA Independence S
Autor:
Elena Garralda, Alonso Guzman, Juanita Lopez, Vicky Sanchez-Perez, Heinz Läubli, Emiliano Calvo, Christoph Huber, Nicole Egli, Aswathy Nair, Julie Mouton, Kirsten Richter, Carlo Lanza, Sangeeta Jethwa, Silvio Costanzo, Christoph Bucher
Publikováno v:
Cancer Research. 82:CT140-CT140
Developing a safe and effective non-alpha IL-2R agonist to enhance the numbers and activation status of immune effector cells for the treatment of cancer has remained an elusive goal since the initial approval of Interleukin-2 (IL-2). ANV419 comprise
Autor:
Heinz Läubli, Guzman Alonso, Juanita Suzanne Lopez, Emiliano Calvo, Vicky Sanchez Perez, Daniela Di Blasi, Aswathy Nair, Kirsten Richter, Christoph Huber, Nicole Egli, Julie Mouton, Silvio Costanzo, Andreas Katopodis, Sangeeta Jethwa Schnetzler, Christoph Marcus Bucher, Elena Garralda
Publikováno v:
Journal of Clinical Oncology. 40:e21552-e21552
e21552 Background: IL-2R agonists that are well tolerated and can selectively enhance immune activation may improve outcomes of patients with cancer. ANV419 is a potent and highly selective IL-2Rβγ binding agonist, consisting of an antibody specifi
Autor:
Anne Skalicky, Dylan Trundell, Stephanie Le Scouiller, Hannah Staunton, Owen Cooper, Asha Hareendran, Tim Seabrook, Ksenija Gorni, Sangeeta Jethwa, Stefan J. Cano, Louise Barrett
Publikováno v:
Journal of the Neurological Sciences. :117318
Background The amount of assistance required to perform daily activities for individuals with Type 2 and non-ambulant Type 3 spinal muscular atrophy (SMA) is often cited as meaningful for quality of life, and important to routinely assess. Methods Th
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.